Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Bio-orthogonal engineered peptide: A multi-functional strategy for the gene therapy of osteoporotic bone loss — Wei Wang (2023) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Bio-orthogonal engineered peptide: A multi-functional strategy for the gene therapy of osteoporotic bone loss
Shared by
Paul Kim Ho Chu
Bio-orthogonal engineered peptide: A multi-functional strategy for the gene therapy of osteoporotic bone loss
Article
2023
en
Authors
+9 more
WW
Wei Wang
QW
Qing Wang
LY
Lei Yu
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Chapter in a book
2024
Gene Therapy as a New Emerging Strategy for Prostate Cancer
Samaneh Adelian
,
Amin Soltani
,
Michael R Hamblin
Article
2025
Peptide‐Oligonucleotide Nanohybrids Designed for Precise Gene Therapy of Rheumatoid Arthritis
Qing Wang
,
Xiaole Peng
,
Xiaoting Gao
,
Yi Qin
,
Wenhao Li
,
Zebin Wu
,
Zhiqi Lao
,
Ang Gao
,
Zhuo Mao
,
Yaozeng Xu
,
Paul Kim Ho Chu
,
Xin Zhao
,
Dechun Geng
,
Huaiyu Wang
Article
2015
Multi-modal imaging for assessment of tissue-engineered bone in a critical-sized calvarial defect mouse model
K. A. Wartella
,
V. Khalilzad-Sharghi
,
Matthew L. Kelso
,
Joy L. Kovar
,
David Kaplan
,
Huihui Xu
,
Shadi F. Othman
Article
2007
Control of Osteoclast Activity and Bone Loss by IKK Subunits: New Targets for Therapy
Maria Grazia Ruocco
,
Michael Karin
Preprint
2024
A Bio-Inspired 3d Bone Model: Mimicking Cortical-Sponge Bone Architecture and Biology for Enhanced Physiological Representation of Bone
Ana Raquel Bastos
,
Lucília P. da Silva
,
Rui L Reis
,
Vítor M. Correlo
Discussion(0)
No comments yet. Be the first to comment.